Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manni Wang

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Nature|January 20, 2021
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Nature|July 30, 2020
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Nature|January 20, 2021
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Nature|July 30, 2020
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Pageof 8